Published in J Appl Physiol (1985) on February 14, 2013
Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function. Brain Behav Immun (2014) 1.04
Muscle disuse alters skeletal muscle contractile function at the molecular and cellular levels in older adult humans in a sex-specific manner. J Physiol (2014) 1.02
Skeletal muscle myofilament adaptations to aging, disease, and disuse and their effects on whole muscle performance in older adult humans. Front Physiol (2014) 0.89
Epigenetic mechanisms in respiratory muscle dysfunction of patients with chronic obstructive pulmonary disease. PLoS One (2014) 0.88
Age-related structural alterations in human skeletal muscle fibers and mitochondria are sex specific: relationship to single-fiber function. J Appl Physiol (1985) (2014) 0.86
Chronic disuse and skeletal muscle structure in older adults: sex-specific differences and relationships to contractile function. Am J Physiol Cell Physiol (2015) 0.81
Motor protein function in skeletal abdominal muscle of cachectic cancer patients. J Cell Mol Med (2013) 0.81
Molecular Background of miRNA Role in Asthma and COPD: An Updated Insight. Biomed Res Int (2016) 0.77
Molecular determinants of force production in human skeletal muscle fibers: effects of myosin isoform expression and cross-sectional area. Am J Physiol Cell Physiol (2015) 0.77
Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia. Am J Physiol Heart Circ Physiol (2015) 0.77
Exercise-based oncology rehabilitation: leveraging the cardiac rehabilitation model. J Cardiopulm Rehabil Prev (2015) 0.77
Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseases. Biology (Basel) (2014) 0.77
Random myosin loss along thick-filaments increases myosin attachment time and the proportion of bound myosin heads to mitigate force decline in skeletal muscle. Arch Biochem Biophys (2014) 0.76
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine. J Cachexia Sarcopenia Muscle (2016) 0.75
MODERATE-INTENSITY RESISTANCE EXERCISE ALTERS SKELETAL MUSCLE MOLECULAR AND CELLULAR STRUCTURE AND FUNCTION IN INACTIVE, OLDER ADULTS WITH KNEE OSTEOARTHRITIS. J Appl Physiol (1985) (2017) 0.75
Muscle structure and theories of contraction. Prog Biophys Biophys Chem (1957) 32.09
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction. Proc Natl Acad Sci U S A (1988) 5.09
Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem (2009) 4.90
Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab (2012) 3.29
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr (1990) 3.24
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest (2004) 3.09
Strength and cross-sectional area of human skeletal muscle. J Physiol (1983) 2.76
Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst (2009) 2.20
Skeletal muscle performance determined by modulation of number of myosin motors rather than motor force or stroke size. Cell (2007) 2.19
The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol (2003) 2.15
Crossbridge scheme and the kinetic constants of elementary steps deduced from chemically skinned papillary and trabecular muscles of the ferret. Circ Res (1993) 1.84
Skeletal muscle power: a critical determinant of physical functioning in older adults. Exerc Sport Sci Rev (2012) 1.83
Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol (2009) 1.75
Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol (1985) (2003) 1.72
The effect of the lattice spacing change on cross-bridge kinetics in chemically skinned rabbit psoas muscle fibers. II. Elementary steps affected by the spacing change. Biophys J (1993) 1.56
Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw (2008) 1.55
Functional heterogeneity of mammalian single muscle fibres: do myosin isoforms tell the whole story? Pflugers Arch (2001) 1.50
Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer. Ann Thorac Surg (2012) 1.49
Age-related differences in skeletal muscle protein synthesis: relation to markers of immune activation. Am J Physiol Endocrinol Metab (2004) 1.42
Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer (2010) 1.40
Whole-muscle and single-fibre contractile properties and myosin heavy chain isoforms in humans. Pflugers Arch (1996) 1.37
Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal (2011) 1.34
Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium. Am J Physiol Heart Circ Physiol (2004) 1.33
Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med (2010) 1.32
The 6-minute walk test in mobility-limited elders: what is being measured? J Gerontol A Biol Sci Med Sci (2002) 1.30
Two-state model of acto-myosin attachment-detachment predicts C-process of sinusoidal analysis. Biophys J (2007) 1.29
Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer (2011) 1.26
Which impairments are most associated with high mobility performance in older adults? Implications for a rehabilitation prescription. Arch Phys Med Rehabil (2008) 1.26
Skeletal muscle force and actomyosin ATPase activity reduced by nitric oxide donor. J Appl Physiol (1985) (1997) 1.23
Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion (2008) 1.19
Muscle oxidative capacity during IL-6-dependent cancer cachexia. Am J Physiol Regul Integr Comp Physiol (2010) 1.19
Morphometric analyses of human muscle fiber types. Muscle Nerve (1982) 1.18
Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans. J Physiol (2010) 1.17
Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol (2009) 1.15
Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease. J Physiol (2011) 1.15
Alterations of myocardial dynamic stiffness implicating abnormal crossbridge function in human mitral regurgitation heart failure. Circ Res (2002) 1.15
Mechanisms underlying skeletal muscle weakness in human heart failure: alterations in single fiber myosin protein content and function. Circ Heart Fail (2009) 1.13
Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol (2009) 1.13
Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats. FEBS Lett (2005) 1.09
The deleterious effects of bed rest on human skeletal muscle fibers are exacerbated by hypercortisolemia and ameliorated by dietary supplementation. Am J Physiol Cell Physiol (2007) 1.09
Resistance training alters skeletal muscle structure and function in human heart failure: effects at the tissue, cellular and molecular levels. J Physiol (2011) 1.03
Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol (2008) 0.99
Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia. J Mol Med (Berl) (2007) 0.97
Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol (1985) (2012) 0.96
Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc (2011) 0.96
Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function. Clin Nutr (2012) 0.95
Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2alpha may signal skeletal muscle atrophy in weight-losing cancer patients. Br J Cancer (2007) 0.94
Enhanced protein electrophoresis technique for separating human skeletal muscle myosin heavy chain isoforms. Electrophoresis (1999) 0.93
Change in health-related quality of life of newly diagnosed cancer patients, cancer survivors, and controls. Cancer (2009) 0.93
Nitric oxide impairs Ca2+ activation and slows cross-bridge cycling kinetics in skeletal muscle. J Appl Physiol (1985) (2001) 0.89
Myosin heavy chain is not selectively decreased in murine cancer cachexia. Int J Cancer (2011) 0.89
Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies. Clin Cancer Res (2012) 0.89
In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD. Eur Respir J (2003) 0.89
Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training. J Appl Physiol (1985) (2012) 0.88
Decreased Jun-D and myogenin expression in muscle wasting of human cachexia. Am J Physiol Endocrinol Metab (2009) 0.88
Isokinetic contractile properties of the quadriceps with relation to fiber type. Eur J Appl Physiol Occup Physiol (1981) 0.87
Force-generating capacity of human myosin isoforms extracted from single muscle fibre segments. J Physiol (2010) 0.84
Muscle paralysis and myosin loss in a patient with cancer cachexia. Acta Myol (2007) 0.83
Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer (2003) 0.83
Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity. Int J Radiat Oncol Biol Phys (2005) 0.81
Skeletal muscle determinants of maximum aerobic power in man. Eur J Appl Physiol Occup Physiol (1980) 0.80
The Massey Bedside Swallowing Screen. J Neurosci Nurs (2002) 0.80
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. J Clin Oncol (2008) 9.43
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol (2006) 4.97
A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development (2004) 3.97
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol (2005) 2.86
Impact of muscle power and force on gait speed in disabled older men and women. J Gerontol A Biol Sci Med Sci (2004) 1.82
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst (2013) 1.81
Antiemetic guidelines: creating a more practical treatment approach. Support Care Cancer (2002) 1.71
Chlamydomonas IFT172 is encoded by FLA11, interacts with CrEB1, and regulates IFT at the flagellar tip. Curr Biol (2005) 1.68
Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function. J Appl Physiol (1985) (2010) 1.59
Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement. Support Care Cancer (2010) 1.51
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med (2013) 1.51
Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck (2010) 1.46
Lower extremity power training in elderly subjects with mobility limitations: a randomized controlled trial. Aging Clin Exp Res (2008) 1.43
Extracts from the Cochrane Library: homeopathic medicines for adverse effects of cancer treatments. Otolaryngol Head Neck Surg (2009) 1.39
Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study. Support Care Cancer (2010) 1.37
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. Cancer (2005) 1.37
The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials. Eur J Cancer (2005) 1.36
Direct interactions of intraflagellar transport complex B proteins IFT88, IFT52, and IFT46. J Biol Chem (2010) 1.31
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer (2003) 1.30
Two-state model of acto-myosin attachment-detachment predicts C-process of sinusoidal analysis. Biophys J (2007) 1.29
Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives. J Natl Compr Canc Netw (2012) 1.27
Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci U S A (2003) 1.25
DNA damage and breast cancer risk. Carcinogenesis (2003) 1.19
Reduced knee extensor function in heart failure is not explained by inactivity. Int J Cardiol (2009) 1.13
Subunit interactions and organization of the Chlamydomonas reinhardtii intraflagellar transport complex A proteins. J Biol Chem (2011) 1.11
Age-related changes in oxidative capacity differ between locomotory muscles and are associated with physical activity behavior. Appl Physiol Nutr Metab (2012) 1.04
Resistance training alters skeletal muscle structure and function in human heart failure: effects at the tissue, cellular and molecular levels. J Physiol (2011) 1.03
Age-related resistance to skeletal muscle fatigue is preserved during ischemia. J Appl Physiol (1985) (2007) 1.01
Never-smokers, never-drinkers: unique clinical subgroup of young patients with head and neck squamous cell cancers. Head Neck (2010) 1.01
Phosphorylation and the N-terminal extension of the regulatory light chain help orient and align the myosin heads in Drosophila flight muscle. J Struct Biol (2009) 0.99
Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res (2013) 0.98
Age-related slowing of myosin actin cross-bridge kinetics is sex specific and predicts decrements in whole skeletal muscle performance in humans. J Appl Physiol (1985) (2013) 0.98
Outcomes of a combined antegrade and retrograde approach for dilatation of radiation-induced esophageal strictures (with video). Gastrointest Endosc (2010) 0.97
Paramyosin phosphorylation site disruption affects indirect flight muscle stiffness and power generation in Drosophila melanogaster. Proc Natl Acad Sci U S A (2005) 0.97
In vivo oxidative capacity varies with muscle and training status in young adults. J Appl Physiol (1985) (2009) 0.96
Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors. Laryngoscope (2005) 0.96
Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study. Brain Imaging Behav (2013) 0.96
Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo. Nutr Cancer (2011) 0.96
Effect of resistance training on physical disability in chronic heart failure. Med Sci Sports Exerc (2011) 0.96
Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients. J Support Oncol (2011) 0.95
Defining cancer cachexia in head and neck squamous cell carcinoma. Clin Cancer Res (2007) 0.93
Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast (2013) 0.92
Molecular biology of head and neck cancer: risks and pathways. Hematol Oncol Clin North Am (2008) 0.91
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy. J Clin Oncol (2009) 0.90
Chromobacterium violaceum necrotizing fasciitis: a case report and review of the literature. Ear Nose Throat J (2012) 0.90
Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training. J Appl Physiol (1985) (2012) 0.88
Effect of weight loss on short-term outcomes and costs of care after head and neck cancer surgery. Ann Otol Rhinol Laryngol (2014) 0.88
Management of patients receiving long-term treatment with mifepristone. Fertil Steril (2005) 0.88
New directions in supportive care. Support Care Cancer (2004) 0.88
Cardiorespiratory fitness in breast cancer patients: a call for normative values. J Am Heart Assoc (2014) 0.87
Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity. Exp Hematol (2004) 0.87
Metabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexia. J Cachexia Sarcopenia Muscle (2013) 0.87
Thick-to-thin filament surface distance modulates cross-bridge kinetics in Drosophila flight muscle. Biophys J (2012) 0.86
Short hospital stay after neck dissection. Otolaryngol Head Neck Surg (2005) 0.85
High XRCC1 protein expression is associated with poorer survival in patients with head and neck squamous cell carcinoma. Clin Cancer Res (2011) 0.84
Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer. Carcinogenesis (2011) 0.82
Passive stiffness in Drosophila indirect flight muscle reduced by disrupting paramyosin phosphorylation, but not by embryonic myosin S2 hinge substitution. Biophys J (2006) 0.82
Cancer cachexia update in head and neck cancer: Definitions and diagnostic features. Head Neck (2014) 0.81
The effect of altered Toll-like receptor 4 signaling on cancer cachexia. Arch Otolaryngol Head Neck Surg (2007) 0.81
COOH-terminal truncation of flightin decreases myofilament lattice organization, cross-bridge binding, and power output in Drosophila indirect flight muscle. Am J Physiol Cell Physiol (2011) 0.81
Muscle weakness, fatigue, and torque variability: effects of age and mobility status. Muscle Nerve (2013) 0.80
Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung. Arch Pathol Lab Med (2009) 0.79
An inverse power-law distribution of molecular bond lifetimes predicts fractional derivative viscoelasticity in biological tissue. Biophys J (2013) 0.79
Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC). Support Care Cancer (2015) 0.79
Translational implications of novel findings in cancer cachexia: the use of metabolomics and the potential of cardiac malfunction. Curr Opin Support Palliat Care (2012) 0.78
Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting. Clin Adv Hematol Oncol (2011) 0.78
Actinomycosis esophagitis in a patient with persistent dysphagia. South Med J (2005) 0.78
Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement. Support Care Cancer (2004) 0.77
Distribution of myosin attachment times predicted from viscoelastic mechanics of striated muscle. J Biomed Biotechnol (2011) 0.77
Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy. Cancer Chemother Pharmacol (2014) 0.76
Malignant mesothelioma following thoracic radiotherapy for lung cancer. Lung Cancer (2007) 0.75
Skeletal muscle adaptations to cancer and its treatment: their fundamental basis and contribution to functional disability. Crit Rev Eukaryot Gene Expr (2013) 0.75
Birth and re-birth. Support Care Cancer (2008) 0.75
When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients. Oncology (2016) 0.75
Uncommon cause of a common disease. South Med J (2003) 0.75
Sex-specific Molecular And Cellular Functional Adaptations To Resistance Training In Inactive Older Adults: 1448 Board #101 June 2, 8: 00 AM - 9: 30 AM. Med Sci Sports Exerc (2016) 0.75
Fitness during Breast Cancer Treatment and Recovery in an Athlete: A Case Study. Med Sci Sports Exerc (2016) 0.75
Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings. Support Care Cancer (2008) 0.75
Aerorespiratory tract cancer in older patients. Semin Oncol (2004) 0.75
Correction to Reparameterization of Solute-Solute Interactions for Amino Acid-Sugar Systems Using Isopiestic Osmotic Pressure Molecular Dynamics Simulations. J Chem Theory Comput (2017) 0.75